Update of guidelines for patient self-management of oral anticoagulation;Aktualisierte leitlinie "gerinnungsselbstmanagement"

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 14, 2009, Pages 695-700

  Braun, S ^a   Völler, Heinz ^b,e   Soppa, C ^c   Taborski, U ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Abteilung fur Kardiologie   (Germany)

^c Kinderärztliche Praxisgemeinschaft   (Germany)

^d Deutsche Gesellschaft für Humanplasma   (Germany)

^e FESC   (Germany)

Author keywords

Anticoagulation; Self testing; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

DRUG INDICATION; MEDICAL CARE; OUTCOME ASSESSMENT; OUTPATIENT; PRACTICE GUIDELINE; REVIEW; SELF CARE; BLOOD CLOTTING TEST; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DRUG SELF ADMINISTRATION; ECONOMICS; HUMAN; PATIENT EDUCATION; QUALITY CONTROL; STANDARD;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; HUMANS; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; QUALITY CONTROL; SELF ADMINISTRATION;

EID: 63149159854     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1208103     Document Type: Review

References (49)

1. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441-1447 (Pubitemid 23191051)
2. Ansell J, Hirsh J, Hylek E, Jacobson A et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S-198
3. Ansell JE, Patel N, Ostrovsky D et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995; 155: 2185-2189
4. Bereznicki LR, Jackson SL, Peterson GM et al. Accuracy and clinical utility of the CoaguChek® XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007; 60: 311-314
5. Bernardo A, Taborski U, Wittstamm FJ. Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation: Standards und Informationen. URL: http:// www.asaev.de [Stand: 13.05.2008]
6. Bernardo A, Voller H Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation A. Leitlinie "Gerinnungsselbstmanagement". Dtsch Med Wochenschr 2001; 126: 346-351
7. Beyth RJ, Quinn L, Landefeld CS. A Multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: a randomized, controlled trial. Ann Intern Med 2000; 133: 687-695 (Pubitemid 30822659)
8. Biasiolo A, Rampazzo P, Furnari O et al. Comparison between routine laboratory prothrombin time measurements and fingerstick determinations using a near-patient testing device (Pro-Time(R)). Thromb Res 2000; 97: 495-498 (Pubitemid 30125717)
9. Bodin L, Verstuyft C, Tregouet DA et al. Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. Blood 2005; 106: 135-140 (Pubitemid 40967184)
10. Braun S, Watzke H, Hasenkam JM et al. Performance evaluation of the new CoaguChek® XS system compared with the established CoaguChek® system by patients experienced in INR-self management. Thrombosis Haemost 2007; 97: 310-314 (Pubitemid 46592153)
11. Braun SL, Soppa C, Taborski U, Völler H. Qualitätssicherung der Patientenschulung zur Selbstkontrolle der Antikoagulation. Z ärztl Fortbild Qual Gesundhwes 2007; 101: 194-195
12. Bundesministerium der Justiz. Bekanntmachung der Spitzenverbände der Krankenkassen - Fortschreibung des Hilfsmittelverzeichnisses. Produktgruppe 21 "Messgeräte für Körperzustände/-funktionen". Bundesanzeiger 2002; 54: 18805
13. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM. Self-management of oral anticoagulant therapy: A systematic review and meta-analysis. Int J Cardiol 2007; 118: 54-61 (Pubitemid 46517685)
14. Cromheecke ME, Levi M, Colly LP et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102 (Pubitemid 30438510)
15. Dorfman DM, Goonan EM, Boutilier MK et al. Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med 2005; 10: 23-27
16. Douketis JD, Lane A, Milne J et al. Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-17 (Pubitemid 28475326)
17. Fitzmaurice DA, Murray ET, Gee KM et al. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002; 55: 845-849
18. Gadisseur APA, Kaptein AA, Breukink-Engbers WGM et al. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost 2004; 2: 584-591
19. Hasenkam JM, Kimose HH, Knudsen L et al. Self management of oral anticoagulant therapy after heart valve replacement. Europ J Cardiothorac Surg 1997; 11: 935-942 (Pubitemid 27261896)
20. Heidinger KS, Bernardo A, Taborski U, Muller-Berghaus G. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Thromb Res 2000; 98: 287-293 (Pubitemid 30255932)
21. Heneghan C, Alonso-Coello P, Garcia-Alamino J et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411 (Pubitemid 43184260)
22. Horstkotte D, Piper C, Wiemer M. Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease. J Thromb Thrombolys 1998; 5: 19-24
23. ISO. Clinical laboratory testing and in vitro diagnostic test systems - Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy.In: ISO ed (Hrsg). International Organization for Standardization. 2003: 38
24. Koertke H, Minami K, Bairaktaris A et al. INR self-management following mechanical heart valve replacement. J Thromb Thrombolys 2000; 9: S41-S45 (Pubitemid 30456028)
25. Koertke H, Zittermann A, Tenderich G et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J 2007; 28: 2479-2484 (Pubitemid 47614293)
26. Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001; 72: 44-48
27. Lafata JE, Martin SA, Kaatz S, Ward RE. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med 2000; 15: 31-37 (Pubitemid 30060936)
28. Leichsenring I, Plesch W, Unkrig V et al. Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Thromb Haemost 2007; 97: 856-861 (Pubitemid 46779971)
29. Menendez-Jandula B, Souto JC, Oliver A et al. Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial. Ann Intern Med 2005; 142: 1-10
30. Müller-Beißenhirtz W, Deickert F, Lang H et al. Selbstkontrolle der oralen Antikoagulation: Standortbestimmung. J Lab Med 1997; 21: 558-562
31. Newall F, Bauman M. Point-of-care antithrombotic monitoring in children. Thromb Res 2006; 118: 113-121
32. Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek(TM) S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-593 (Pubitemid 44414947)
33. Piso B, Jimenz-Boj E, Krinninger B, Watzke HH. The quality of oral anticoagulation before, during and after a period of patient self-management. Thromb Res 2002; 106: 101-104 (Pubitemid 35245232)
34. Rost S, Fregin A, Ivaskevicius V et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537-541 (Pubitemid 38209110)
35. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999; 281: 145-150
36. Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a twoyear prospective randomized trial with heart valve patients. Ann Thorac Surg 2001; 72: 1523-1527 (Pubitemid 33049754)
37. Siebenhofer A, Rakovac I, Kleespies C et al. Self-management of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year of follow-up. Thromb Haemost 2007; 97: 408-416 (Pubitemid 46437803)
38. Sunderji R, Gin K, Shalansky K et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Can J Cardiol 2004; 20: 1117-1123 (Pubitemid 39302738)
39. Taborski U, Braun SL, Völler H. Analytical Performance of the New Coagulation Monitoring System INRatio™ for the Determination of INR Compared with the Coagulation Monitor Coaguchek® S and an Established Laboratory Method. J Thromb Thrombolys 2004; 18: 103-107 (Pubitemid 40485115)
40. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost 1999; 25: 103-107 (Pubitemid 29202985)
41. van den Besselaar AM, Breddin K, Lutze G et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagula Fibrinolysis 1995; 6: 726-732 (Pubitemid 26047202)
42. van den Besselaar AM, Meeuwisse-Braun J et al. A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis 2000; 11: 559-562
43. van den Besselaar AM. Accuracy, precision, and quality control for pointof- care testing of oral anticoagulation. J Thromb Thrombolys 2001; 12: 35-40
44. Voeller H, Dovifat C, Glatz J et al. Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442-447 (Pubitemid 39491067)
45. Voeller H, Dovifat C, Wegscheider K. Experience with INR self-management: patient selection and complication rates. Z Kardiol 2005; 94: 801-807 (Pubitemid 43029747)
46. Völler H, Glatz J, Taborski U et al. Self-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study). Z Kardiol 2005; 94: 182-186 (Pubitemid 40394900)
47. Völler H, Taborski U, Dovifat C et al. ProTime® self-management yielding improvement of fluency and quality of life. Thromb Haemost 2007; 98: 889-895 (Pubitemid 47555084)
48. Watzke HH, Forberg E, Svolba G et al. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000; 83: 661-665 (Pubitemid 30248510)
49. White RH, McCurdy SA, von Marensdorff H et al. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 1989; 111: 730-737